What role for AHR activation in IL4I1-mediated immunosuppression ?

The amino-acid catabolizing enzyme Interleukin-4 induced gene 1 (IL4I1) remains poorly characterized despite it is emerging as a pertinent therapeutic target for cancer. IL4I1 is secreted in the synaptic cleft by antigen-presenting cells. It inhibits TCR signaling, modulates naïve T cell differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellano, Flavia, Prevost-Blondel, Armelle, Cohen, José L., Molinier-Frenkel, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118450/
https://www.ncbi.nlm.nih.gov/pubmed/34026337
http://dx.doi.org/10.1080/2162402X.2021.1924500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118450/
https://www.ncbi.nlm.nih.gov/pubmed/34026337
http://dx.doi.org/10.1080/2162402X.2021.1924500

Ejemplares similares